Please try another search
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, and commercialization of therapies that address unmet medical needs in the People’s Republic of China. It is developing various drugs that cover ophthalmic indications, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Yu Chen | 46 | - | Non Executive Director |
Hin Wing Wong | 61 | 2021 | Independent Non-Executive Director |
Tiantian Zhang | 40 | 2021 | Non Executive Director |
Xiangrong Dai | 43 | 2020 | Executive Director |
Lam Lo Yuk | 74 | 2021 | Independent Non-Executive Director |
Xiaoyi Li | 60 | 2017 | Chairman of the Board & CEO |
Leelalertsuphakun Wanee | 69 | 2017 | Non-Executive Director |
Fui Kiang Liew | 58 | 2022 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review